Adagene (ADAG) is trading down at $2.80 (-1.75%), as of the latest quote. It operates in the Health Care sector.
| FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.51M | $480.0K | $700.9K | $10.2M | $9.29M | $18.1M | $103.2K | $7.67M |
| Growth (year over year) | — | −68.2% | +46.0% | +1351.7% | −8.7% | +94.9% | −99.4% | +7332.8% |
| Operating income | −$17.3M | −$19.2M | −$43.2M | −$72.4M | −$83.9M | −$23.7M | −$36.0M | −$21.4M |
| Operating margin | −1147.1% | −3993.7% | −6156.5% | −711.2% | −903.1% | −131.0% | −34835.4% | −279.5% |
| Net income | −$15.3M | −$16.4M | −$42.4M | −$73.2M | −$80.0M | −$18.9M | −$33.4M | −$17.6M |
| Net margin | −1010.2% | −3423.4% | −6048.9% | −719.2% | −860.6% | −104.6% | −32386.4% | −229.6% |
| EPS (diluted) | −$0.94 | −$1.10 | −$2.67 | −$1.46 | −$1.48 | −$0.35 | −$0.59 | −$0.30 |
| Balance sheet | ||||||||
| Cash and equivalents | $16.1M | $92.5M | $75.2M | $174.4M | $143.8M | $109.9M | $85.2M | $74.5M |
| Total assets | — | $105.9M | $84.3M | $189.5M | $152.4M | $115.7M | $89.3M | $78.3M |
| Total liabilities | — | $8.70M | $19.2M | $33.0M | $69.3M | $45.2M | $38.7M | $26.4M |
| Long-term debt | — | $1.52M | $2.97M | $2.99M | $14.1M | $13.5M | $417.3K | $1.14M |
| Shareholders' equity | −$41.0M | −$57.0M | −$89.4M | $156.6M | $83.1M | $70.6M | $50.5M | $35.3M |
| Cash flow | ||||||||
| Operating cash flow | −$14.3M | −$18.2M | −$28.5M | −$43.4M | −$48.6M | −$28.5M | −$29.7M | −$15.7M |
| Capital expenditure | $514.7K | $151.8K | $935.2K | $2.51M | $690.9K | $85.0K | $33.6K | $17.1K |
| Free cash flow | −$14.8M | −$18.3M | −$29.5M | −$45.9M | −$49.3M | −$28.5M | −$29.7M | −$15.7M |
| Share buybacks | — | — | — | $2.36M | $3.98M | — | — | — |
From Adagene's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Adagene in our feed yet.